Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3969)
All Articles published online
|
Publishing Process of This Article
|
Apr 26, 2023 (publication date) through May 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ohtake T, Itaba S, Salybekov AA, Sheng Y, Sato T, Yanai M, Imagawa M, Fujii S, Kumagai H, Harata M, Asahara T, Kobayashi S. Repetitive administration of cultured human CD34+ cells improve adenine-induced kidney injury in mice. World J Stem Cells 2023; 15(4): 268-280 [PMID: 37181001 DOI: 10.4252/wjsc.v15.i4.268] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v15/i4/268.htm |
| Number | Citing Articles |
| 1 |
Nicolas Gendron, Benjamin Planquette, Anne Roche, Richard Chocron, Dominique Helley, Aurélien Philippe, Pierre-Emmanuel Morange, Pascale Gaussem, Olivier Sanchez, David M. Smadja. Circulating CD34+ Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism. Stem Cell Reviews and Reports 2025; doi: 10.1007/s12015-025-10865-0
|
| 2 |
Anne Aries, Christine Vignon, Céline Zanetti, Aurélien Goubaud, Arthur Cormier, Anne Diederichs, Rachid Lahlil, Philippe Hénon, Ibon Garitaonandia. Development of a potency assay for CD34+ cell-based therapy. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47079-8
|
| 3 |
Takayasu Ohtake, Tsutomu Sato, Toshitaka Tsukiyama, Suguru Muraoka, Ayaka Mitomo, Haruka Maruyama, Mizuki Yamano, Yasuhiro Mochida, Kunihiro Ishioka, Machiko Oka, Hidekazu Moriya, Sumi Hidaka, Haruchika Masuda, Takayuki Asahara, Shuzo Kobayashi. Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34<sup>+</sup> cell therapy: A clinical trial. World Journal of Stem Cells 2024; 16(12): 1012-1021 doi: 10.4252/wjsc.v16.i12.1012
|